Business
The Rhythm (ASX:RHY) share price surges on cancer testing milestone
The Rhythm Biosciences Ltd (ASX: RHY) share price has opened higher on Tuesday after the successful completion of Study 6 for its ColoSTAT product. At the time of writing, the Rhythm share price is trading at $1.60, up 6.33%.
Let’s take a closer look at this announcement and what it means for the Rhythm share price.
Why the Rhythm share price opened higher on Tuesday
The Rhythm share price has surged. Climbing from a low of 3.5 cents 12-months ago to a high of $1.675 on 2 March. The company continues to hit significant milestones. In particular, for the commercialisation of its simple, affordable, and effective ColoSTAT blood test….
-
General17 hours agoJannik Sinner reveals secret Wimbledon bet that could keep Darren Cahill in his team
-
Noosa News21 hours agoAustralia Zoo reunites with the Ukrainian community
-
Noosa News21 hours ago“Hidden gem”: last chance for renovated bayside homes below $1m
-
Business18 hours agoASX retail share whose ‘fundamentals have deteriorated significantly’: expert